WANETAM-4 West African Network of Excellence for TB, AIDS and Malaria
- Coordinator
- European & Developing Countries Clinical Trials Partnership, Netherlands
- Runs
- 1 July 2026 to 30 June 2031
- Status
- Running
- EU funding
- €12.8m
- Total cost
- —
- Partners
- 30 organisations in 14 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101248831
What the project is doing
In the project's own words, from its summary on CORDIS.
The West Africa Networks of Excellence for TB, AIDS, and Malaria (WANETAM) has developed over 3 previous funding cycles for research capacity development in West Africa. The WANETAM-4 proposal will build upon the achievements of the previous cycles to further enhance expertise in clinical research and stronger linkages to global partners and national public Health Institutions (PHIs), with a vision to attain sustainable capacity for conducting clinical research and safeguarding against epidemics in the region.
WANETAM-4 will implement its activities through 8 Work Programs, including TB, Malaria, HIV, Special Collaborative Training on Epidemic Preparedness and Surveillance (SCTEPS), Cross-Cutting Training (C-C), Clinical Trial Preparedness, Scientific Program Management, and Dissemination and Exploitation. The TB program aims to unravel the burden and determinants of TB multimorbidity and its impact on treatment outcome, whilst building expertise at partner institutions including PHIs.
It will also collaborate with the LSHTM TB Centre, QURE.AI and IAVI to further strengthen capacity for transdisciplinary research on TB. The Malaria program will build capacity to support PHIs to achieve malaria pre-elimination and elimination in the region. It will address disparities in capacity for genomic surveillance, clinical trials, entomology, epidemiology and modelling for African ownership innovation and context-specific interventions for elimination.
The HIV program will aim to map out challenges in rapid early childhood diagnosis, to improve data on drug-resistance mutations, and collaborate with the Global HIV vaccine Enterprise of the IAS for capacity training. The lessons learnt from COVID-19 impelled the development of the SCTEPS program, in which training in epidemic preparedness will be in synergy with regional programs and the Scientific Program Management will coordinate with the C-C training program to achieve research expertise.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| European & Developing Countries Clinical Trials Partnership | Den Haag | Netherlands | Coordinator |
| Instituut Voor Tropische Geneeskunde | Antwerpen | Belgium | Participant |
| Centre National De Recherche Scientifique Et Technologique*institut De Recherche En Sciences De La Sante | Ouagadougou | Burkina Faso | Participant |
| Groupe De Recherche Action En Sante SARL | Ouagadougou | Burkina Faso | Participant |
| Institut National De Sante Publique | Ouagadougou | Burkina Faso | Participant |
| Fondation Pour La Recherche Scientifique (fors) | Cotonou | BJ | Participant |
| Universite D'abomey-Calavi | Abomey Calavi | BJ | Participant |
| European Vaccine Initiative eV | Heidelberg | Germany | Participant |
| Forschungszentrum Borstel Leibniz Lungenzentrum | Borstel | Germany | Participant |
| Institut De Recherche Pour Le Developpement | Marseille | France | Participant |
| University of Ghana | Accra | Ghana | Participant |
| L'Hopital National Donka | Conakry | GN | Participant |
| Ministere De La Sante Et Lhygiene Publique | Kaloum | GN | Participant |
| Instituto Nacional De Saude Publica | Bissau | GW | Participant |
| Universite Des Sciences Des Techniques Et Des Technologies De Bamako | Bamako | ML | Participant |
| Ahmadu Bello University | Zaria | NG | Participant |
| College of Medicine | Ibadan | NG | Participant |
| Institute of Human Virology Nigeria Ltdgte | Abuja | NG | Participant |
| Jos University Teaching Hospital | Jos | NG | Participant |
| Nigerian Institute of Medical Research | Lagos | NG | Participant |
| West African Research and Innovation Management Association Warima Ltd | Ibadan | NG | Participant |
| Stichting International Aids Vaccine Initiative the Netherlands | Amsterdam | Netherlands | Participant |
| Instituto Piaget Coop Para O Desenvimento Humano Integral Ecologico Crl | Canelas Vila Nova De Gaia | Portugal | Participant |
| Universidade Nova De Lisboa | Lisboa | Portugal | Participant |
| Institut Pasteur De Dakar | Dakar | SN | Participant |
| Reseau Africain De Recherche En Sante | Dakar | SN | Participant |
| Universite Cheikh Anta Diop De Dakar | Dakar Fann | SN | Participant |
| London School of Hygiene and Tropical Medicine Royal Charter | London | United Kingdom | Participant |
| Malaria Consortium | London | United Kingdom | Participant |
| Qure.ai | Birmingham | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI